Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-29

Clinical Trial Update: Effect of LIXIsenatide on the Renal System [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of lixisenatide on renal outcomes in patients with diabetic kidney disease and related conditions has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lixisenatide (lixisenatide)

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Diabetic Kidney Disease, Diabetic Nephropathy | Phase 4 | Status: COMPLETED